1 |
Zhang H, Chen F, Giang E, Bao F, Lauer GM, Marsh C, Law M, Pockros PJ. Virus reactivation in a non-cirrhotic HBV patient requiring liver transplantation after cessation of nucleoside analogue therapy. Antiviral Therapy 2021;26:3-8. [DOI: 10.1177/13596535211042205] [Reference Citation Analysis]
|
2 |
Liang J, Liang X, Ma H, Nie L, Tian Y, Chen G, Wang Y. Detection of Hepatitis B Virus M204V Mutation Quantitatively via Real-time PCR. J Clin Transl Hepatol 2021;9:143-8. [PMID: 34007795 DOI: 10.14218/JCTH.2020.00118] [Reference Citation Analysis]
|
3 |
Liu Y, Chang S, Martin R, Flaherty J, Mo H, Feierbach B. Characterization of Hepatitis B virus polymerase mutations A194T and CYEI and tenofovir disoproxil fumarate or tenofovir alafenamide resistance. J Viral Hepat 2021;28:30-9. [PMID: 32894807 DOI: 10.1111/jvh.13397] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
4 |
Shang J, Zhou J, Liu H, Ise RM, Tu Y, Ran J, Bai L, Tang H. Efficacy of different nucleoside analog rescue therapies for entecavir-resistant chronic hepatitis B patients. BMC Infect Dis 2021;21:912. [PMID: 34488678 DOI: 10.1186/s12879-021-06554-1] [Reference Citation Analysis]
|
5 |
Wang R, Xie Z. A Simple and Rapid Method for Quantitative Detection of Hepatitis B Virus Drug-resistant Mutations. J Clin Transl Hepatol 2021;9:139-40. [PMID: 34007793 DOI: 10.14218/JCTH.2021.00135] [Reference Citation Analysis]
|